Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.

导出 LinkOut

翻译打印收藏纠错

作者： Chanikarn,Tongruang ^[1] ; Siriwan,Wananukul ^[2] ; Susheera,Chatproedprai ^[2] ; Nattee,Narkbunnam ^[3] ; Rattanavalai,Nitiyarom ^[4] ; Nongnuch,Sirachainan ^[5] ; Rungrote,Natesirinilkul ^[6] ; Phumin,Chaweephisal ^[7] ; Darintr,Sosothikul ^[1]

作者单位： Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. ^[1] Division of Dermatology, Department of Pediatrics, Faculty of Medicine King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. ^[2] Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. ^[3] Division of Dermatology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. ^[4] Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. ^[5] Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Chiang Mai University Hospital, Chiang Mai University, Chiang Mai, Thailand. ^[6] The Integrative and Innovative Hematology/Oncology Research Unit, Faculty of Medicine Chulalongkorn University, Bangkok, Thailand. ^[7]

关键词 Direct-cost analysis Kasabach-Merritt phenomenon Sirolimus